Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Clinical trial NCT01873157 · COMPLETED

Trial details

NCT number: NCT01873157
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Late Rejection of Renal Transplant Antibody-mediated Rejection

Start date: 2013-12-01
Primary completion: 2015-02-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.